4
Changes in Ownership
Fortress Biotech, Inc. Filed Acc 0001104659-21-048831
Director sold 30,000 shares at an average $4.24 ($127,100)
- Director acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Rowinsky Eric K · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-01 | Grant or award : show line 1 in the form | +100,000 | 750,000 | D | ||
| 2021-02-05 | Sale : show line 2 in the form | −4,000 | $3.80 | $15,200 | 746,000 | D |
| 2021-02-16 | Sale : show line 3 in the form | −2,000 | $3.86 | $7,720 | 744,000 | D |
| 2021-02-18 | Sale : show line 4 in the form | −6,000 | $4.20 | $25,200 | 738,000 | D |
| 2021-02-19 | Sale : show line 5 in the form | −8,000 | $4.31 | $34,480 | 730,000 | D |
| 2021-03-02 | Sale : show line 6 in the form | −10,000 | $4.45 | $44,500 | 720,000 | D |
| Open-market sales · 30,000 sh · avg $4.24 · $127,100 | ||||||
Loading xslF345X03/tm219139d7_4.xml…